计划剂量报告方法对IROC肺与肝运动模体铅笔束扫描质子Gamma通过率的影响
该研究评估两种计划剂量报告方法对IROC质子肺与肝运动模体2D胶片剂量和模拟3D剂量Gamma分析通过率的影响。结果显示计划4D剂量比计划AVE剂量与实测胶片剂量和模拟3D剂量更匹配,建议向IROC报告计划4D剂量以提高胶片Gamma通过率。
要点
- 计划4D剂量较计划AVE剂量与实测胶片剂量和模拟3D剂量更匹配。
- 使用计划4D剂量使肺模体胶片2D-2D Gamma通过率从92%提高到96%。
- 运动幅度大于1 cm时,计划4D剂量与模拟3D剂量匹配显著优于AVE剂量。
核心结论
- 建议使用计划4D剂量作为机构向IROC报告的计划剂量,与实测胶片剂量比较,以提高质子运动模体胶片Gamma分析通过率。
研究设计与样本
- 研究获取IROC质子肺与肝运动模体的4DCT图像集,肺和肝模体实测固定运动幅度分别为1.3 cm和1.0 cm。
- 通过创建虚拟4DCT图像集模拟每个模体三种运动幅度(扫描运动幅度的50%、100%和200%)。
- 使用RayStation治疗计划系统在4DCT的平均强度投影CT上优化治疗计划。
- 计划AVE剂量在AVE CT上计算;计划4D剂量在所有10个相位CT上计算并按靶区对齐等权重求和至50%相位CT。
- 向IROC报告计划AVE剂量和4D剂量,比较实测胶片剂量相对于两种计划剂量的2D-2D Gamma分析通过率。
主要发现
- 计划4D剂量比计划AVE剂量与实测2D胶片剂量和模拟交付3D剂量匹配更好。
- 使用计划4D剂量作为报告剂量,肺模体三张胶片2D-2D Gamma分析通过率(7% 5 mm)平均从92%提高到96%。
- 使用计划4D剂量作为报告剂量,肝模体矢状面2D-2D Gamma分析通过率(7% 4 mm)从92%提高到94%。
- 3D-3D Gamma分析(3% 3 mm)显示,对于大于1 cm的模体运动,使用10个随机束起始相位的肺和肝模体模拟交付剂量与计划4D剂量匹配显著优于计划AVE剂量(p ≤ 0.04)。
关键数值与推荐
- 肺模体胶片2D-2D Gamma分析标准为7% 5 mm。
- 肝模体矢状面胶片2D-2D Gamma分析标准为7% 4 mm。
- 3D-3D Gamma分析标准为3% 3 mm。
- 计划4D剂量使肺模体胶片Gamma通过率平均从92%提高到96%。
- 计划4D剂量使肝模体矢状面胶片Gamma通过率从92%提高到94%。
临床怎么用
- 在IROC认证过程中,质子运动模体应向IROC报告计划4D剂量而非计划AVE剂量,以提高胶片Gamma分析通过率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study is to evaluate the impact of two methods of reporting planned dose distributions on the Gamma analysis pass rates for comparison with measured 2D film dose and simulated delivered 3D dose for proton pencil beam scanning treatment of the Imaging and Radiation Oncology Core (IROC) proton lung and liver mobile phantoms. METHODS AND MATERIALS: Four-dimensional (4D) computed-tomography (CT) image sets were acquired for IROC proton lung and liver mobile phantoms, which include dosimetry inserts that contains targets, thermoluminescent dosimeters and EBT2 films for plan dose verification. 4DCT measured fixed motion magnitudes were 1.3 and 1.0 cm for the lung and liver phantoms, respectively. To study the effects of motion magnitude on the Gamma analysis pass rate, three motion magnitudes for each phantom were simulated by creating virtual 4DCT image sets with motion magnitudes scaled from the scanned phantom motion by 50, 100, and 200%. The internal target volumes were contoured on the maximum intensity projection CTs of the 4DCTs for the lung phantom and on the minimum intensity projection CTs of the 4DCTs for the liver phantom. Treatment plans were optimized on the average intensity projection (AVE) CTs of the 4DCTs using the RayStation treatment planning system. Plan doses were calculated on the AVE CTs, which was defined as the planned AVE dose (method one). Plan doses were also calculated on all 10 phase CTs of the 4DCTs and were registered using target alignment to and equal-weight-summed on the 50% phase (T50) CT, which was defined as the planned 4D dose (method two). The planned AVE doses and 4D doses for phantom treatment were reported to IROC, and the 2D-2D Gamma analysis pass rates for measured film dose relative to the planned AVE and 4D doses were compared. To evaluate motion interplay effects, simulated delivered doses were calculated for each plan by sorting spots into corresponding respiratory phases using spot delivery time recorded in the log files by the beam delivery system to calculate each phase dose and accumulate dose to the T50 CTs. Ten random beam starting phases were used for each beam to obtain the range of the simulated delivered dose distributions. 3D-3D Gamma analyses were performed to compare the planned 4D/AVE doses with simulated delivered doses. RESULTS: The planned 4D dose matched better with the measured 2D film dose and simulated delivered 3D dose than the planned AVE dose. Using planned 4D dose as institution reported planned dose to IROC improved IROC film dose 2D-2D Gamma analysis pass rate from 92 to 96% on average for three films for the lung phantom (7% 5 mm), and from 92 to 94% in the sagittal plane for the liver phantom (7% 4 mm), respectively, compared with using the planned AVE dose. The 3D-3D Gamma analysis (3% 3 mm) pass rate showed that the simulated delivered doses for lung and liver phantoms using 10 random beam starting phases for each delivered beam matched the planned 4D dose significantly better than the planned AVE dose for phantom motions larger than 1 cm (p ≤ 0.04). CONCLUSIONS: It is recommended to use the planned 4D dose as the institution reported planned dose to IROC to compare with the measured film dose for proton mobile phantoms to improve film Gamma analysis pass rate in the IROC credentialing process.
引用
- Kang Y, Shen J, Liu W, et al. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol. 2019. PMID: 31208439. doi:10.1186/s13014-019-1316-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。